Aerobic Exercise Training Response in Preterm-Born Young Adults with Elevated Blood Pressure and Stage 1 Hypertension: A Randomized Clinical Trial
Burchert H., Lapidaire W., Williamson W., McCourt A., Dockerill C., Woodward W., Tan CMJ., Bertagnolli M., Mohamed A., Alsharqi M., Hanssen H., Huckstep OJ., Leeson P., Lewandowski AJ.
Abstract Rationale Premature birth is an independent predictor of long-term cardiovascular risk. Individuals affected are reported to have a lower rate of V˙ o 2 at peak exercise intensity (V˙ o 2PEAK) and at the ventilatory anaerobic threshold (V˙ o 2VAT), but little is known about their response to exercise training. Objectives The primary objective was to determine whether the V˙ o 2PEAK response to exercise training differed between preterm-born and term-born individuals; the secondary objective was to quantify group differences in V˙ o 2VAT response. Methods Fifty-two preterm-born and 151 term-born participants were randomly assigned (1:1) to 16 weeks of aerobic exercise training (n = 102) or a control group (n = 101). Cardiopulmonary exercise tests were conducted before and after the intervention to measure V˙ o 2PEAK and the V˙ o 2VAT. A prespecified subgroup analysis was conducted by fitting an interaction term for preterm and term birth histories and exercise group allocation. Measurements and Main Results For term-born participants, V˙ o 2PEAK increased by 3.1 ml/kg/min (95% confidence interval [CI], 1.7 to 4.4), and the V˙ o 2VAT increased by 2.3 ml/kg/min (95% CI, 0.7 to 3.8) in the intervention group versus controls. For preterm-born participants, V˙ o 2PEAK increased by 1.8 ml/kg/min (95% CI, −0.4 to 3.9), and the V˙ o 2VAT increased by 4.6 ml/kg/min (95% CI, 2.1 to 7.0) in the intervention group versus controls. No significant interaction was observed with birth history for V˙ o 2PEAK (P = 0.32) or the V˙ o 2VAT (P = 0.12). Conclusions The training intervention led to significant improvements in V˙ o 2PEAK and V˙ o 2VAT, with no evidence of a statistically different response based on birth history. Clinical trial registered with www.clinicaltrials.gov (NCT02723552).
